# FDA Warning Letter: Profounda, Inc.
> 2023-03-14 · Division of Pharmaceutical Quality Operations II · `6dbbf6256ccdfa34`
## Letter
- **Company:** Profounda, Inc.
- **Posted Date:** 2023-03-14
- **Letter Issue Date:** 2023-02-01
- **Issuing Office:** Division of Pharmaceutical Quality Operations II
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*